On Tuesday, Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)’s shares surged 10.65% to $5.09, after Brainstorm Cell declared that results from its phase 2a study of NurOwn® in amyotrophic lateral sclerosis (ALS) and additional analyses will be presented at the American Academy of Neurology annual meeting, taking place in Washington D.C. from April 18 to 25, 2015.
NurOwn® is an autologous cell therapy in which bone marrow-derived mesenchymal stem cells are expanded and then, under proprietary conditions, induced to secrete several neurotrophic factors known to promote neuronal survival. BrainStorm has accomplished two clinical trials of these neurotrophic factor-secreting mesenchymal stem cells in Israel, and is presently enrolling a randomized, double-blind, placebo-controlled phase 2 study at three centers in the United States.
Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis.
Key Energy Services Inc. (NYSE:KEG)’s shares gained 9.29% to $2.00, during the last trading session on Tuesday, as Key Energy will report first quarter 2015 financial results after market close on Wednesday, April 29, 2015, and Key administration will host a conference call to talk about these results on Thursday, April 30, 2015 at 10:00 a.m. CDT.
Key Energy Services, Inc. operates as an onshore rig-based well servicing contractor in the United States and internationally. It offers rig-based services, counting the maintenance, workover, and recompletion of existing oil wells; completion of newly-drilled wells; and plugging and abandonment of wells at the end of their lives, in addition to specialty drilling services to oil and natural gas producers.
At the end of Tuesday’s trade, Cara Therapeutics Inc. (NASDAQ:CARA)’s shares gained 9.22% to $11.96, as there’s a growing and increasingly vocal body of researchers showing that cannabidiol (“CBD”) - the non-psychoactive component of the cannabis plant - could provide substantial health benefits. While GW Pharmaceuticals plc (NASDAQ:GWPH) has pioneered clinical trials in the space, this research suggests that the company is just scratching the surface of what may be possible using natural phytocannabinoids.
According to Project CBD, an advocacy group, CBD could serve as a potential treatment in areas like pain administration, oncology, neurological disorders, cardiovascular disease, antibiotic resistance, and more. Studies focused on cannabinoids are being conducted by a number of different companies, counting Cannabis Science Inc. (CBIS) and Cara Therapeutics Inc. (CARA).
Peak Pharmaceuticals Inc. (PKPH) is aiming to become a sector leader focused on delivering the potential health benefits of CBD and other phytocannabionds to humans and animals. While the FDA prohibits companies from making health claims without clinical trials, the HIA v. DIA court decision cleared the way for hemp-based foods to be sold as nutritional supplements throughout the United States.
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors.
Finally, Clean Energy Fuels Corp. (NASDAQ:CLNE), ended its Tuesday’s trading session with 9.17% gain, and closed at $6.55, after Clean Energy Fuels Corp. (CLNE), declared fueling has begun at two new compressed natural gas (CNG) fueling station in Southern California in addition to two new truck-friendly CNG stations in Lake Havasu City, Ariz., and Kansas City, Kan. The company also received industry recognition for its new NGV Easy Bay® from Heavy Duty Trucking Magazine in addition to the top transit engineering honor at the Canadian Deputy Minister’s Consulting Engineers Awards.
Clean Energy Fuels Corp. provides natural gas as an alternative fuel for vehicle fleets in the United States and Canada. It designs, builds, operates, and maintains fueling stations; and supplies compressed natural gas (CNG) fuel for light, medium, and heavy-duty vehicles, in addition to liquefied natural gas (LNG) fuel for medium and heavy-duty vehicles.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
